Cell Lung Carcinoma clinical trials

Explore recruiting cell lung carcinoma clinical trials.

Recruiting cell lung carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cell Lung Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prospective feasibility pilot study evaluating the value of [68Ga]Ga-PENTIXAFOR PET-CT in patients with locally advanced or metastatic Small Cell Lung Cancer (SCLC) at diagnosis and disease progression (PASSIFLORE)

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

Phase I trial of CArbonic Anhydrase Inhibition in combination with radiochemotherapy or radioimmunotherapy in small cell lung carcinoma (ICAR)

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

Dose tapering and Early Discontinuation to InCreAse cosT-effictIveness Of immunotherapy for Non-small cell lung carcinoma trial number 1 (NVALT-30 - Dedication-1)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

A study to test different doses of obrixtamig (BI 764532) combined with ezabenlimab in patients with Small Cell Lung Carcinoma and other neuroendocrine neoplasms expressing DLL3

Belgium, France, Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Study Investigating Tucatinib and Osimertinib Pharmacokinetics in Primary and Metastatic Brain Tumors: the STICK trial

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

DAREON™-8: A study to test how well different doses of BI 764532 in addition to standard of care are tolerated by people with advanced small cell lung cancer

Poland, Belgium, France, Germany, Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Cell Lung Carcinoma trials by city

Cell Lung Carcinoma in Toronto Cell Lung Carcinoma in Vancouver Cell Lung Carcinoma in Montreal Cell Lung Carcinoma in Calgary Cell Lung Carcinoma in Edmonton Cell Lung Carcinoma in Ottawa Cell Lung Carcinoma in Winnipeg Cell Lung Carcinoma in Quebec City Cell Lung Carcinoma in Hamilton Cell Lung Carcinoma in Kitchener Cell Lung Carcinoma in London Cell Lung Carcinoma in Halifax Cell Lung Carcinoma in New York Cell Lung Carcinoma in Los Angeles Cell Lung Carcinoma in Chicago Cell Lung Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease